These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 22444951)
1. Neurocognition, psychopathology, and subjective disturbances in schizophrenia: a comparison between short-term and remitted patients. Comparelli A; De Carolis A; Corigliano V; Romano S; Kotzalidis G; Brugnoli R; Tamorri S; Curto M; Tatarelli R; Ferracuti S; Girardi P Compr Psychiatry; 2012 Oct; 53(7):931-9. PubMed ID: 22444951 [TBL] [Abstract][Full Text] [Related]
2. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder. Houthoofd SA; Morrens M; Sabbe BG Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365 [TBL] [Abstract][Full Text] [Related]
3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
4. [Influence of attention on an auditory-verbal learning test in schizophrenic patients]. Huguelet P; Nicastro R; Zanello A Encephale; 2002; 28(4):291-7. PubMed ID: 12232538 [TBL] [Abstract][Full Text] [Related]
5. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia. Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774 [TBL] [Abstract][Full Text] [Related]
6. Cognitive deficit awareness in schizophrenia: absent, intact, or somewhere in-between? Balzan RP; Neaves A; Denson LA; Liu D; Galletly C Cogn Neuropsychiatry; 2014; 19(6):471-84. PubMed ID: 24749790 [TBL] [Abstract][Full Text] [Related]
7. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685 [TBL] [Abstract][Full Text] [Related]
8. Executive attention deficits in schizophrenia: putative mandatory and differential cognitive pathology domains in medicated schizophrenia patients. Meiron O; Hermesh H; Katz N; Weizman A Psychiatry Res; 2013 Aug; 209(1):1-8. PubMed ID: 23102537 [TBL] [Abstract][Full Text] [Related]
9. [MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia]. Jedrasik-Styła M; Ciołkiewicz A; Denisiuk M; Linke M; Parnowska D; Gruszka A; Jarema M; Wichniak A Psychiatr Pol; 2012; 46(2):261-71. PubMed ID: 23214396 [TBL] [Abstract][Full Text] [Related]
10. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior. Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765 [TBL] [Abstract][Full Text] [Related]
11. Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication. Snyder PJ; Jackson CE; Piskulic D; Olver J; Norman T; Maruff P Psychiatry Res; 2008 Sep; 160(3):316-26. PubMed ID: 18579217 [TBL] [Abstract][Full Text] [Related]
15. [Measuring the cognitive deficit associated with schizophrenia: presentation of the MATRICS neuropsychological test battery]. Sarolta K; Pál C; István B Neuropsychopharmacol Hung; 2007 Oct; 9(3):143-50. PubMed ID: 18399033 [TBL] [Abstract][Full Text] [Related]
16. Serum testosterone levels are related to cognitive function in men with schizophrenia. Moore L; Kyaw M; Vercammen A; Lenroot R; Kulkarni J; Curtis J; O'Donnell M; Carr VJ; Shannon Weickert C; Weickert TW Psychoneuroendocrinology; 2013 Sep; 38(9):1717-28. PubMed ID: 23490072 [TBL] [Abstract][Full Text] [Related]
17. Morphological correlates to cognitive dysfunction in schizophrenia as studied with Bayesian regression. Laywer G; Nyman H; Agartz I; Arnborg S; Jönsson EG; Sedvall GC; Hall H BMC Psychiatry; 2006 Aug; 6():31. PubMed ID: 16901336 [TBL] [Abstract][Full Text] [Related]
18. Relationship of affect recognition with psychopathology and cognitive performance in schizophrenia. Bozikas VP; Kosmidis MH; Anezoulaki D; Giannakou M; Karavatos A J Int Neuropsychol Soc; 2004 Jul; 10(4):549-58. PubMed ID: 15327733 [TBL] [Abstract][Full Text] [Related]
19. Recovery in schizophrenia: focus on neurocognitive functioning. Zaytseva Y; Gurovich IY; Goland E; Storozhakova YA Psychiatr Danub; 2012 Sep; 24 Suppl 1():S172-5. PubMed ID: 22945216 [TBL] [Abstract][Full Text] [Related]
20. Deficits in neurocognition, theory of mind, and social functioning in patients with schizophrenic disorders: are they related? Bâ MB; Zanello A; Varnier M; Koellner V; Merlo MC J Nerv Ment Dis; 2008 Feb; 196(2):153-6. PubMed ID: 18277224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]